Global Antibody Therapeutics and Blood Antibody Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Antibody Therapeutics and Blood Antibody Therapeutics market size will reach 277,027 Million USD in 2025 and is projected to reach 543,983 Million USD by 2032, with a CAGR of 10.12% (2025-2032). Notably, the China Antibody Therapeutics and Blood Antibody Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Antibody therapy refers to a specific type of medicine that uses antibodies to fight or prevent disease. Antibodies are proteins produced by the immune system that recognize and bind to specific molecules (called antigens) to trigger an immune response. Scientists have developed techniques to generate monoclonal antibodies that can be produced in large quantities and used as drugs to treat a variety of diseases, including cancer, autoimmune diseases and infectious diseases. Blood antibody therapy usually refers to the use of plasma containing high levels of antibody molecules, called convalescent plasma, which is obtained from people who have recovered from a particular disease. This plasma can be infused into patients currently infected with the same disease to provide passive immunity to help them fight infection.

The major global suppliers of Antibody Therapeutics and Blood Antibody Therapeutics include Roche, Abbvie, Johnson & Johnson, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda, Amgen, Biogen, Eli Lilly and Company, UCB, AstraZeneca, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Antibody Therapeutics and Blood Antibody Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Antibody Therapeutics and Blood Antibody Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Antibody Therapeutics and Blood Antibody Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Antibody Therapeutics and Blood Antibody Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Antibody Therapeutics and Blood Antibody Therapeutics Include:

Roche

Abbvie

Johnson & Johnson

Bristol-Myers Squibb

Novartis

Merck

Alexion Pharmaceuticals

Takeda

Amgen

Biogen

Eli Lilly and Company

UCB

AstraZeneca

Antibody Therapeutics and Blood Antibody Therapeutics Product Segment Include:

IgG1

IgG4

Others

Antibody Therapeutics and Blood Antibody Therapeutics Product Application Include:

Autoimmune

Tumor

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Antibody Therapeutics and Blood Antibody Therapeutics Industry PESTEL Analysis

Chapter 3: Global Antibody Therapeutics and Blood Antibody Therapeutics Industry Porter's Five Forces Analysis

Chapter 4: Global Antibody Therapeutics and Blood Antibody Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Antibody Therapeutics and Blood Antibody Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more